# Progress — orchestrator_2

Last visited: 2026-10-24T11:40:30Z

## Current Status
- [x] Initialized orchestrator_2 workspace, DISPATCH.md, BRIEFING.md, plan.md, GATE_STATUS.md
- [x] Started heartbeat cron (task-22)
- [x] Milestone 4 Gate Verification:
  - [x] Dispatched reviewer_m4_1_gen2 (20251677-2d5d-4ff8-a047-332ca68c1306), reviewer_m4_2_gen2 (e51d155b-b3c4-44eb-9cf1-64415a8cda26)
  - [x] Dispatched challenger_m4_1_gen2 (442318b2-f65e-43ac-8b64-07ebaa686074), challenger_m4_2_gen2 (f8759729-5db1-4984-a87c-13947d47c530)
  - [x] Dispatched auditor_m4_1_gen2 (b333471f-5244-4758-856c-9eb724dcddab)
  - [x] Evaluated Gate M4: PASS (reviewer_1: APPROVE, reviewer_2: APPROVE, challenger_1: APPROVE, challenger_2: APPROVE, auditor: CLEAN)
- [x] Phase 3: Full-battery E2E & existing test suites verification:
  - [x] Dispatched worker_phase3 (cc9c8912-7587-46c9-b5a5-d2eaf4e1fa7d)
  - [x] Full-battery test execution: 890 tests passed (242/242 in tests/e2e, 114/114 in research/evaluation, 357/357 in causal-engine, 177/177 in sbom-service)
- [x] Phase 4: Tier 5 Adversarial Coverage Hardening:
  - [x] Dispatched challenger_t5_1 (89fd26c7-4bf5-48fa-9f07-5aac78793c9a) for Causal Engine & Preflight Guards (96 tests in test_tier5_causal_adversarial.py: APPROVE)
  - [x] Dispatched challenger_t5_2 (28bca2d4-c2fe-41c3-9f7f-855cdc7481b7) for Metrics & Reporting (51 tests in test_tier5_metrics_adversarial.py: APPROVE)
  - [x] Total E2E tests: 389 passed across Tiers 1-5 (100% green, zero gaps remaining)
- [x] Phase 5: Final Project-Wide Audit & Deterministic Reporting:
  - [x] Dispatched worker_final_reporting (a2e9a323-e672-420e-bde7-968520e59010)
  - [x] Dispatched auditor_final (a5993f2f-5277-44d8-a9fd-33f6f95b1f1d)
  - [x] Artifact synchronization verified; 100% deterministic outputs in output/ and results3/
  - [x] Final Forensic Audit: CLEAN (Zero integrity violations across all requirements R1–R6)
- [x] Final Completion & Human Reporting

## Iteration Status
Current iteration: 5 / 32
Milestone: Complete (All Acceptance Criteria Met)
